Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | CPB1 | P15086 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.43 |
| ▸ | CTSL | P07711 | 1/20 | 0.42 |
| ▸ | CTSB | P07858 | 1/20 | 0.42 |
| ▸ | CTSK | P43235 | 1/20 | 0.42 |
| ▸ | KDM1A | O60341 | 2/20 | 0.42 |
| ▸ | MAOB | P27338 | 2/20 | 0.42 |
| ▸ | MAOA | P21397 | 1/20 | 0.42 |
| ▸ | TLR4 | O00206 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30221997 | 0.88 | ALDH1A1 (0.56) | ALDH1A1GAACPB1TSHREPHX1 | |
| SCHEMBL8886224 | 0.84 | ALDH1A1 (0.49) | ALDH1A1GAACPB1TSHREPHX1 | |
| SCHEMBL4386420 | 0.82 | ALDH1A1 (0.53) | ALDH1A1GAACPB1TSHREPHX1 | |
| SCHEMBL3203924 | 0.82 | ALDH1A1 (0.53) | ALDH1A1GAACPB1TSHREPHX1 | |
| SCHEMBL4379957 | 0.82 | ALDH1A1 (0.53) | ALDH1A1GAACPB1TSHREPHX1 | |
| SCHEMBL3204209 | 0.82 | ALDH1A1 (0.53) | ALDH1A1GAACPB1TSHREPHX1 | |
| SCHEMBL19437142 | 0.82 | ALDH1A1 (0.53) | ALDH1A1GAACPB1TSHREPHX1 | |
| SCHEMBL3219056 | 0.82 | ALDH1A1 (0.53) | ALDH1A1GAACPB1TSHREPHX1 | |
| SCHEMBL3223441 | 0.82 | ALDH1A1 (0.53) | ALDH1A1GAACPB1TSHREPHX1 | |
| SCHEMBL13643316 | 0.80 | CPB1 (0.50) | ALDH1A1GAACPB1TSHREPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220340893-A1 | BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES | NUEVOLUTION A/S (DK) | 2022-10-27 | — | — | US | disclosed |
| US-11225655-B2 | Bi-functional complexes and methods for making and using such complexes | NUEVOLUTION A/S (DK) | 2022-01-18 | — | — | US | disclosed |
| EP-3540059-A1 | BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES | Nuevolution A/S (DK) | 2019-09-18 | — | — | EP | disclosed |
| EP-2558577-B1 | BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES | NUEVOLUTION AS (DK) | 2018-12-12 | — | — | EP | disclosed |
| US-20130281324-A1 | BI-FUNCTINAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES | NUEVOLUTION A/S (DK) | 2013-10-24 | — | — | US | disclosed |
| EP-2558577-A1 | BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES | Nuevolution A/S (DK) | 2013-02-20 | — | — | EP | disclosed |
| WO-2011127933-A1 | BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES | NUEVOLUTION A/S (DK) | 2011-10-20 | — | — | WO | disclosed |
| US-5650535-A | FORMING NORBORNENE BY CHEMICAL CONDENSATION OF UNSATURATED ESTER WITH CYCLOPENTADIENE IN TRIETHYLAMINE | G. D. SEARLE & CO. (US) | 1997-07-22 | — | — | US | disclosed |
| US-5541344-A | 5-HT AGONISTS, ANTAGONISTS, IODINATED TRICYLIC LACTONES | G. D. SEARLE & CO. (US) | 1996-07-30 | — | — | US | disclosed |